K12 Special Notes

This is an NCI-specific program announcement. For all of the policies governing this award mechanism, refer to the Program Announcement: PAR-10-155 PAUL CALABRESI AWARD FOR CLINICAL ONCOLOGY (K12).

Recommended Tables

Summary Information on Program (We have created suggested tabular formats for your convenience. "Click on" TABLES (Word for Windows) or TABLES (Adobe for Acrobat Files), which ever you prefer to download this information.

Special Institutional Statement Regarding Human Subjects Research Under K12 Support

The National Cancer Institute (NCI) Paul Calabresi Career Development Award for Clinical Oncology (K12) must be in compliance with all NIH/NCI policies pertaining to the use of human subjects. These policies apply to all research involving human subjects, not just clinical trials. The K12 is a training and career development grant in which candidate positions are filled at the discretion of the institution and assignment of candidate positions is generally not known at the time of application or at the time of an award. Due to this uncertainty, the word "Indefinite" should be placed in the box for IRB review date on the face page of the application and the applicant institution must provide in the submitted grant application a Special Statement on Human Subjects Research.

The complete Special Institutional Statement Regarding Human Subjects Research Under K12 Support may be accessed by clicking K12 Special Institutional Statement Regarding Human Subjects Research.

Inquiries:

Inquiries are encouraged, and the opportunity to clarify any issues or questions is welcome. Inquiries should be sent to:

Dr. Ming Lei
Program Director
Telephone: (301) 496-8580
Fax: (301) 480-1744
E-mail: leim@mail.nih.gov